Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Prognostic Factors for T-Cell Acute Lymphoblastic Leukemia in Children and Young Adults: ALL-T11 Study Conducted By Japan Children's Cancer Group and Japan Adult Leukemia Study Group

Blood (2024) 144 (Supplement 1): 1426.

https://doi.org/10.1182/blood-2024-199500

Published: 2024

Journal Articles

Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms

Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki, Rika Kanezaki, Kiminori Terui, Ryunosuke Saiki, Masami Ojima, Yotaro Ochi, Seiya Mizuno, Masaharu Yoshihara, Tamayo Uechi, Naoya Kenmochi, Shiro Tanaka, Jun Matsubayashi, Kenta Kisai, Ko Kudo, Kentaro Yuzawa, Yuka Takahashi, Tatsuhiko Tanaka, Yohei Yamamoto, Akie Kobayashi, Takuya Kamio, Shinya Sasaki, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Hideki Muramatsu, Asahito Hama, Daisuke Hasegawa, Atsushi Sato, Katsuyoshi Koh, Shuhei Karakawa, Masao Kobayashi, Junichi Hara, Yuichi Taneyama, Chihaya Imai, Daiichiro Hasegawa, Naoto Fujita, Masahiro Yoshitomi, Shotaro Iwamoto, Genki Yamato, Satoshi Saida, Nobutaka Kiyokawa, Takao Deguchi, Masafumi Ito, Hidemasa Matsuo, Souichi Adachi, Yasuhide Hayashi, Takashi Taga, Akiko M. Saito, Keizo Horibe, Kenichiro Watanabe, Daisuke Tomizawa, Satoru Miyano, Satoru Takahashi, Seishi Ogawa, Etsuro Ito

Blood (2024) 143 (25): 2627–2643.

https://doi.org/10.1182/blood.2023022247

Published: 2024

Includes: Supplemental data

Journal Articles

A Nationwide Clinical Trial ALL-B12: An Optimized Therapy for Pediatric B-Precursor Acute Lymphoblastic Leukemia with Excellent Overall Survival and Minimal Non-Relapse Mortality: A Report from the Japan Children's Cancer Group

Blood (2023) 142 (Supplement 1): 519.

https://doi.org/10.1182/blood-2023-182464

Published: 2023

Journal Articles

Risk Stratified Therapy with Nelarabine and Intensified Administration of L-Asparaginase for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults (JPLSG T-11/JALSG T-ALL-211-U): An Intergroup Phase 2 Study

Blood (2022) 140 (Supplement 1): 124–126.

https://doi.org/10.1182/blood-2022-156613

Published: 2022

Journal Articles

Impact of Nelarabine, Intensive L-Asparaginase, and Protracted Intrathecal Therapy on Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group and the Japan Adult Leukemia Study Group

Blood (2021) 138 (Supplement 1): 3393.

https://doi.org/10.1182/blood-2021-149110

Published: 2021

Journal Articles

A Novel Method for Highly Efficient Ex Vivo Expansion and Genetic Engineering of Human Natural Killer Cells for Cancer Therapy

Nobuhiro Kubo, Yudai Murayama, Yasushi Kasahara, Chansu Shin, Minori Baba, Ryosuke Hosokai, Haruko Iwabuchi, Imamura Masaru, Akihiko Saitoh, Chihaya Imai

Blood (2021) 138 (Supplement 1): 2850.

https://doi.org/10.1182/blood-2021-152356

Published: 2021

Journal Articles

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Haruko Shima, MD PhD, Akiko Kada, MPH, Akihiko Tanizawa, MD PhD, Yuki Yuza, MD PhD, Akihiro Watanabe, Masaki Ito, MD, Hideko Uryu, Katsuyoshi Koh, MD, Chihaya Imai, MD PhD, Nao Yoshida, MD PhD, Yuhki Koga, MD, Naoto Fujita, MD PhD, Akiko M Saito, MD PhD, Souichi Adachi, MD PhD, Eiichi Ishii, MD PhD, Hiroyuki Shimada, MD PhD

Blood (2019) 134 (Supplement_1): 25.

https://doi.org/10.1182/blood-2019-122623

Published: 2019

Journal Articles

BRAF V600E-Positive Precursors As Molecular Markers of Bone Marrow Involvement in Pediatric Langerhans Cell Histiocytosis

Ko Kudo, MD, Rika Kanezaki, PhD, Akie Kobayashi, MD, Tomohiko Sato, MD PhD, Takuya Kamio, MD PhD, Shinya Sasaki, MD PhD, Imamura Masaru, MD PhD, Chihaya Imai, MD PhD, Masahiro Irie, MD PhD, Yoji Sasahara, MD PhD, Kumiko Ando, MD, Harumi Kakuda, MD PhD, Takehiko Doi, MD PhD, Hiroshi Kawaguchi, MD PhD, Kazuko Kudo, MD PhD, Hirokazu Kanegane, MD PhD, Kiminori Terui, MD PhD, Tsutomu Toki, PhD, Etsuro Ito, MD PhD

Blood (2019) 134 (Supplement_1): 3588.

https://doi.org/10.1182/blood-2019-127536

Published: 2019

Journal Articles

Nationwide Survey of Pediatric Hypodiploid Acute Lymphoblastic Leukemia in Japan

Blood (2017) 130 (Supplement 1): 5121.

https://doi.org/10.1182/blood.V130.Suppl_1.5121.5121

Published: 2017

Journal Articles

Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG /NEMO mutations

Blood (2017) 130 (12): 1456–1467.

https://doi.org/10.1182/blood-2017-03-771600

Published: 2017

Includes: Supplemental data

Journal Articles

A Novel NKp44-Based Chimeric Antigen Receptor That Targets Multiple Types of Cancer

Yasushi Kasahara, MD, Changsu Shin, MD, Sakiko Yoshida, MD PhD, Takayuki Takachi, MD PhD, Nobuhiro Kubo, MD, Haruko Iwabuchi, MD PhD, Masaru Imamura, MD PhD, Akihiko Saitoh, MD PhD, Chihaya Imai, MD PhD

Blood (2016) 128 (22): 3517.

https://doi.org/10.1182/blood.V128.22.3517.3517

Published: 2016

Journal Articles

Interleukin-21 Gene Transduction in Human Natural Killer Cells Enhances Their Anti-Leukemic Capacity

Yasushi Kasahara, MD, Changsu Shin, MD, Takayuki Takachi, MD PhD, Haruko Iwabuchi, MD PhD, Masaru Imamura, MD PhD, Akihiko Saitoh, MD PhD, Chihaya Imai, MD PhD

Blood (2015) 126 (23): 5425.

https://doi.org/10.1182/blood.V126.23.5425.5425

Published: 2015

Journal Articles

Augmented Consolidation Therapy Based on Minimal Residual Disease (MRD) and Analysis of the Measurement of Sequential MRD in Childhood Acute Lymphoblastic Leukemia : Children's Cancer and Leukemia Study Group of JAPAN (CCLSG), Cclsg ALL 2004 Protocol Study

Blood (2015) 126 (23): 3724.

https://doi.org/10.1182/blood.V126.23.3724.3724

Published: 2015

Journal Articles

Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15

Masaru Imamura, David Shook, Takahiro Kamiya, Noriko Shimasaki, Sally M. H. Chai, Elaine Coustan-Smith, Chihaya Imai, Dario Campana

Blood (2014) 124 (7): 1081–1088.

https://doi.org/10.1182/blood-2014-02-556837

Published: 2014

Includes: Supplemental data

Journal Articles

Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency

Blood (2012) 119 (23): 5458–5466.

https://doi.org/10.1182/blood-2011-05-354167

Published: 2012

Includes: Supplemental data

Journal Articles

Patients’ Peripheral Blood as a Possible Source of Donor-Derived NK Cells for Ex Vivo Expansion and Genetic Modification for Post-Transplant Cellular Immunotherapy In Cord Blood Recipients

Chihaya Imai, MD, PhD, Sakiko Yoshida, MD, PhD, Takayuki Takachi, MD, Masaru Imamura, MD, PhD, Ryosuke Hosokai, MD, Haruko Iwabuchi, MD, PhD, Makoto Uchiyama, MD, Keiko Asami, MD, Atsushi Ogawa, MD, Akihiro Watanabe, MD

Blood (2010) 116 (21): 2094.

https://doi.org/10.1182/blood.V116.21.2094.2094

Published: 2010

Journal Articles

Interleukin-2 Gene Transduction in Human Natural Killer Cells Augments Their Survival and Anti-Leukemic Capacity

Chihaya Imai, MD, PhD, Takayuki Takachi, MD, Haruko Iwabuchi, MD, PhD, Masaru Imamura, MD, PhD, Tae Nemoto, MD, Dario Campana, MD, PhD, Makoto Uchiyama, MD, PhD

Blood (2008) 112 (11): 5437.

https://doi.org/10.1182/blood.V112.11.5437.5437

Published: 2008

Journal Articles

Simultaneous Use of Histone Deacetylase Inhibitor Valproic Acid Potentiates Natural Killer Cell Cytotoxicity against T-Lineage Acute Lymphoblastic Leukemia

Takayuki Takachi, MD, Chihaya Imai, MD, PhD, Yasushi Kasahara, MD, Masaru Imamura, MD, PhD, Makoto Uchiyama, MD, PhD

Blood (2008) 112 (11): 5438.

https://doi.org/10.1182/blood.V112.11.5438.5438

Published: 2008

Journal Articles

Activated T Cell-Mediated Immunotherapy with a Chimeric Receptor Against CD38 in B-Cell Malignancies.

Keichiro Mihara, MD, PhD, Kazuyoshi Yanagihara, Ph.D, Misato Takigahira, Takahiro Ochiya, Ph.D, Chihaya Imai, M.D., Ph.D, Akira Kitanaka, M.D., Ph.D, Yoshihiro Takihara, M.D., Ph.D, Akiro Kimura, M.D., Ph.D

Blood (2007) 110 (11): 2356.

https://doi.org/10.1182/blood.V110.11.2356.2356

Published: 2007

Journal Articles

Sustained Expansion of Human Natural Killer Cells for Leukemia Therapy.

Hiroyuki Fujisaki, MD, PhD, Harumi Kakuda, MD PhD, Chihaya Imai, MD, Dario Campana, MD PhD

Blood (2006) 108 (11): 3719.

https://doi.org/10.1182/blood.V108.11.3719.3719

Published: 2006

NARROW

Prognostic Factors for T-Cell Acute Lymphoblastic Leukemia in Children and Young Adults: ALL-T11 Study Conducted By Japan Children's Cancer Group and Japan Adult Leukemia Study Group

Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms

A Nationwide Clinical Trial ALL-B12: An Optimized Therapy for Pediatric B-Precursor Acute Lymphoblastic Leukemia with Excellent Overall Survival and Minimal Non-Relapse Mortality: A Report from the Japan Children's Cancer Group

Risk Stratified Therapy with Nelarabine and Intensified Administration of L-Asparaginase for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults (JPLSG T-11/JALSG T-ALL-211-U): An Intergroup Phase 2 Study

Impact of Nelarabine, Intensive L-Asparaginase, and Protracted Intrathecal Therapy on Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group and the Japan Adult Leukemia Study Group

A Novel Method for Highly Efficient Ex Vivo Expansion and Genetic Engineering of Human Natural Killer Cells for Cancer Therapy

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

BRAF V600E-Positive Precursors As Molecular Markers of Bone Marrow Involvement in Pediatric Langerhans Cell Histiocytosis

Nationwide Survey of Pediatric Hypodiploid Acute Lymphoblastic Leukemia in Japan

Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG /NEMO mutations

A Novel NKp44-Based Chimeric Antigen Receptor That Targets Multiple Types of Cancer

Interleukin-21 Gene Transduction in Human Natural Killer Cells Enhances Their Anti-Leukemic Capacity

Augmented Consolidation Therapy Based on Minimal Residual Disease (MRD) and Analysis of the Measurement of Sequential MRD in Childhood Acute Lymphoblastic Leukemia : Children's Cancer and Leukemia Study Group of JAPAN (CCLSG), Cclsg ALL 2004 Protocol Study

Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15

Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency

Patients’ Peripheral Blood as a Possible Source of Donor-Derived NK Cells for Ex Vivo Expansion and Genetic Modification for Post-Transplant Cellular Immunotherapy In Cord Blood Recipients

Interleukin-2 Gene Transduction in Human Natural Killer Cells Augments Their Survival and Anti-Leukemic Capacity

Simultaneous Use of Histone Deacetylase Inhibitor Valproic Acid Potentiates Natural Killer Cell Cytotoxicity against T-Lineage Acute Lymphoblastic Leukemia

Activated T Cell-Mediated Immunotherapy with a Chimeric Receptor Against CD38 in B-Cell Malignancies.

Sustained Expansion of Human Natural Killer Cells for Leukemia Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only